Interleukin-13 has been implicated as a key factor in asthma, allergy, atopy and in¯ammatory response, establishing the protein as a valuable therapeutic target. The high-resolution solution structure of human IL-13 has been determined by multidimensional NMR. The resulting structure is consistent with previous short-chain left-handed four-helix bundles, where a signi®cant similarity in the folding topology between IL-13 and IL-4 was observed. IL-13 shares a signi®cant overlap in biological function with IL-4, a result of the common a chain component (IL-4Ra) in their respective receptors. Based on the available structural and mutational data, an IL-13/IL-4Ra model and a sequential mechanism for forming the signaling heterodimer is proposed for IL-13.
Introduction
Interleukin-13 (IL-13) is a pleiotropic cytokine with roles in atopy, asthma, allergy and in¯amma-tory response.
1 ± 5 IL-13 is produced by activated T-cells and promotes B-cell proliferation, induces B-cells to produce IgE, down-regulates the production of proin¯amatory cytokines, increases expression of VCAM-1 on endothelial cells, enhances the expression of class II MHC antigens and various adhesion molecules on monocytes. IL-13 mediates these functions through an interaction with its receptor on hematopoietic and other cell types, but currently no functional receptors have been identi®ed on T-cells. The signaling human IL-13 receptor (IL-13R) is a heterodimer composed of the interleukin-4 receptor a chain (IL-4Ra) and the IL-13 binding chain. Two IL-13 binding chains that are 27 % homologous have been identi®ed, IL13Ra1 and IL-13Ra2. IL-13Ra2 demonstrates an approximate 100-fold higher af®nity for IL-13 relative to IL-13Ra1 in the absence of IL-4Ra, but has been identi®ed only in the serum and urine of mice. The association of IL-13 with its receptor induces the activation of STAT6 (signal transducer and activation of transcription 6) and Janus-family kinase (JAK1, JAK2, TYK2) through a binding interaction with the IL-4Ra chain.
IL-13 is located in a cluster of genes on chromosome 5 encoding IL-3, IL-4, IL-5, IL-9 and GM-CSF. IL-13 shares many functional properties with IL-4 as a result of the common IL-4Ra component in their receptors. 6, 7 IL-4 exhibits a high af®nity to the IL-4Ra chain (K d 20-300 pM), where this complex recruits the common g chain (g c ) of IL-4R to form the signaling complex. Similarly, IL-13 binds to the IL-13 binding chain (IL-13Ra1) with relatively high af®nity (K d $ 4 nM) in the absence of the IL-4Ra chain, where an increase in af®nity to IL-4R occurs in the presence of IL-4Ra (K d 50 pM). IL-13 does not bind IL-4Ra in the absence of the IL-13 binding chain. As a result, IL-4 exhibits binding to both IL-4R and IL-13R due to the existence of the IL4Ra chain in both receptors, but IL-13 does not bind IL-4R because of the absence of the IL-13 binding chain. 6 The cross-reactivity of IL-4 with both IL-4R and IL-13R is further promoted by the antagonistic activity of the IL-4 Y124D mutant. 8 The IL-4 Y124D mutant still maintains the ability to bind IL-4Ra, but is de®cient in its ability to induce a signal through interaction with the g c chain. Since the g c chain is not present in IL-13R, IL-13 does not induce the proliferation and E-mail address of the corresponding author: powersr@war.wyeth.com Abbreviations used: IL-13, interleukin-13; IL-4, interleukin-4; IL-13R, interleukin-13 receptor; IL-4R, interleukin-4 receptor; IL-4Ra, interleukin-4 receptor a chain; IL-13R-BC, interleukin-13 receptor binding chain, g c , IL-4 receptor common g chain; HMQC, heteronuclear multiple-quantum coherence spectroscopy; NOE, nuclear Overhauser effect; NOESY, nuclear Overhauser enhanced spectroscopy; COSY, correlated spectroscopy. differentiation of T-cells or the activation of JAK-3 kinase, which associates with the g c chain of IL-4R.
IL-13 and IL-4 are both members of the shortchain four-helix bundle cytokine family, 9 where both solution and crystal structures have been determined for IL-4.
10 ± 14 Despite the relatively low (25 %) sequence homology between IL-13 and IL-4, a similarity in the overall topology between the two proteins is expected. A combination of mutational and kinetic analysis has identi®ed a distinct site on the IL-4 structure associated with IL-4Ra binding and a second site associated with signaling through the g c chain. 15 ± 17 Recently, the X-ray structure of IL-4 complexed with the ectodomain of IL4Ra has been determined, which further de®nes the IL-4 -IL-4Ra interface. 18 Despite the abundance of structural information on the IL-4 receptor system, structural information for IL-13, IL-13R or the complex is currently lacking. To further our understanding of the IL-13 receptor system and as part of a structure-based drug design program, we have determined the high-resolution solution structure of human IL-13 by heteronuclear multidimensional NMR. Furthermore, since IL-13 and IL-4 are structural homologs, correlation of the mutational data for both IL-4 and IL-13 with the structure of the IL-4-IL-4Ra complex and the solution structure of IL-13 described herein may provide insight into the IL-13-IL13R complex.
Results and Discussion

IL-13 NMR structure
Nearly complete backbone and side-chain 1 H, 15 N, 13 C, and 13 CO assignments have been obtained for IL-13 that enabled the determination of a high-resolution solution structure for the protein by NMR (Figure 1 ). The IL-13 structure is well de®ned by the NMR data, where a total of 2848 Figure 1 . Strip plots taken from the CBCA(CO)NH and CBCANH spectra for the amide groups of residues E61 through F70 of IL-13. Each amide group correlates with the C a and C b of the preceding residue in the CBCA(CO)NH spectra and with both its intraresidue C a and C
b
, and the C a and C b of the preceding residue in the CBCANH spectra. Interresidue (i À 1) correlations are labeled where the observed interresidue connectivities are markedly thick lines. The correlations associated with a particular amide group are connected with a thin line.
constraints were used to re®ne the structure ( Figure 2 ). This is evident by a best-®t superposition of the backbone atoms shown in Figure 3 , where the atomic r.m.s. distribution of the 30 simulated annealing structures about the mean coordinate positions for residues 1-113 is 0.43(AE0.04) A Ê for the backbone atoms ( Table 1 ). All of the backbone torsion angles for non-glycine residues lie within expected regions of the Ramachandran plot, where 89.9 % of the residues lie within the mostfavored region of the Ramachandran f,c plot, 9.1 % in the additionally allowed region and 1.0 % in the generously allowed region. The high quality of the IL-13 NMR structure is evident also by the results of the PROCHECK analysis, where an overall G-factor of 0.15, a hydrogen bond energy of 0.90 and only 1.8 bad contacts per 100 residues were determined. The calculated PROCHECK parameters for IL-13 are comparable to values obtainable with $1 A Ê X-ray structures and imply a relatively high quality for the structure, but does not infer an inherent resolution. 19 The IL-13 protein adopts the expected lefthanded four-helical bundle with up-up-downdown connectivities previously observed for IL-4 and similar cytokines. The four helical regions correspond to residues 6-22 (a A ), 43 N HSQC spectra for residues in the structural vicinity of C29. In addition to residues sequential to C29 and C57, A93 and residues sequential to A93 exhibited multiple 1 H- 15 N HSQC peaks. Except for the backbone NH resonance assignments, the remainder of the spin-system chemical shifts assignments for these residues were essentially identical. More importantly, the 3D 15 Nedited NOESY spectra exhibited identical NOE patterns and relative intensities for the multiple backbone NH diagonal peaks. Therefore, the chemical shift multiplicity observed in the 2D 1 H- 15 N HSQC spectra suggests a local conformational heterogeneity in the vicinity of C29, where the IL-13 structural change is within the resolution of the structure and the limits of detection for an NOE intensity change. A probable source for the structural heterogeneity is the presence of multiple conformations for the side-chain dihedral angles that comprise the C29-C57 disul®de bond. The C a -C a distance separation for the two cysteine residues involved in a disul®de bond are dependent directly on the side-chain dihedral angles. 20 A distance range of 4.4 to 6.8 A Ê for the C a -C a separation is observed for typical values of dihedral angles observed in a disul®de bond, but distance changes of only 0.1-0.2 A Ê is common between pairs of side-chain conformations. Most likely, a smaller distance change is the source of the heterogeneity present in IL-13, where the different sidechain conformations result in C29 being slightly closer to either C57 or A93. The conformational heterogeneity centered on C29 may also explain the anomalous C b chemical shift for this residue. Another feature of the IL-13 structure is the presence of three long loops connecting the four helices. The shortest loop connects helices a B and a C and comprises residues N53 to S58. The two long overhand connections are comprised of residues N23 to G42, which connects helices a A with a B , and residues C71 to E91, which connects a C with a D . These loops come in close contact to form the short b-sheet. Additionally, the C29-C57 disul®de bond connects the AB loop to the BC loop. The combination of the short b-sheet and the disul®de bond results in regions of these loops being relatively well de®ned. Further stability of the long loops occurs from long-range intermolecular NOEs that result in packing of parts of the loop against the helical bundle.
An another interesting feature of the IL-13 structure is the location of the C45-C71 disul®de bond, which effectively connects the N terminus of a B with the C terminus of a C . Since the a B and a C helices are also connected by the short BC loop, which is further stabilized by the C29-C57 disul®de bond, the orientation of the a B and a C helices is de®ned extensively by covalent connectivity. The end result is a closed loop connecting the a B and a C helices.
Comparison of the IL-13 and IL-4 solution structures
An abundance of structural information for IL-4 has been determined by both NMR and X-ray crystallography, where a reasonable consensus was obtained for the IL-4 structure. 21 Therefore, a single solution structure of IL-4 (PDB ID: 1BBN) was used to simplify the comparison between the solution structure of IL-13 with IL-4.
10,11 Ribbon diagrams for both the IL-13 and IL-4 restrained minimized solution structures are shown in Figure 4 . While the overall folding topology of the two proteins is quite similar, there are obvious distinctions between the two structures. A primary distinction is the overall size difference between the two proteins. IL-4 contains a total of 129 residues compared to 113 for IL-13. This results in the extension of the IL-4 structure by $12 A Ê along the long axis relative to IL-13. Consistent with the overall size difference are variations in the helix lengths between the IL-4 and IL-13 structures. The length of the four helices in IL-4 corresponds to 17, 23, 26 and 16 residues for helices a A , a B , a C and a D , respectively. Conversely, in IL-13 helices a A , a B , a C and a D have lengths of 17, 10, 12 and 17 residues, respectively. Clearly, the most pronounced distinction is between helices a B and a C , where the IL-4 helices are more than double the length of IL-13. Interestingly, a similar difference in the loop regions between the helices was not seen. The length of the AB, BC and CD loops between IL-4 and IL-13 are identical or nearly identical, where the loops in IL-13 are longer by one or two residues. Similarly, the length of the short b-sheet that comprises part of loops AB and CD are essentially identical. Another distinction between the two protein structures is the number and location of the disul®de bonds. IL-4 has a total of three disul®de bonds that connect the N and C terminus (C3-C127), the AB and BC loops (C24-C64), and helix a B to loop CD (C46-C99). Conversely, IL-13 contains only two disul®de bonds that connect the AB and BC loops (C29-C57) and helix a B to helix a C (C45-C71).
A 25 % sequence homology exists between IL-13 and IL-4; however, optimal superposition of the two proteins is determined mainly by alignment of shared secondary structure elements. An overlay of the IL-13 and IL-4 solution structures based on the common secondary structure elements and Cys residues yielded a backbone r.m.s. of 1.44 A Ê . The sequential alignment based on the shared secondary structure elements and Cys residues along with the overlay of the backbone atoms for IL-13 with IL-4 is illustrated in Figure 5 . In general, there is a good agreement in the superposition between the IL-13 and IL-4 structures, including the loop regions. Nevertheless, there exist some distinct differences between the two proteins in the relative orientations and packing of the four-helix bundle, where a B and a D exhibit the largest changes. This is exempli®ed by an observed 20 difference in the interhelical angle between helices a B -a D and changes in opposite directions in the axial separation for helices a A -a B and a C -a D . The a A -a B axial separation decreases from 16.4 A Ê to 12.6 A Ê between IL-13 and IL-4, respectively. Conversely, the a C -a D axial separation increases from 14.2 A Ê to 16.7 A Ê between IL-13 and IL-4. Since a B in IL-13 is the shortest helix and half the length of a B in IL-4, the observed structural changes may be attributed to this change in helix length. Furthermore, the relative orientation of a B in IL-13 is also de®ned by the disul®de bonds at both the N and C-terminal ends of the helix. Comparison of IL-13 with IL-4 indicates that only a partial spatial alignment of the conserved cysteine residues occurs, further contributing to the perturbation in a B . There is a good agreement with the relative orientation of C45 from IL-13 with C46 from IL-4. To a lesser extent, the positioning of C29 from IL-13 agrees with C24 from IL-4. But, there is essentially no correlation between the other members of the disul®de pairs. This difference results from the shorter a B and a C helices in IL-13 and the fact that C99 resides within the CD loop in IL-4 compared to C71 being located in helix a C for IL-13. Despite the highlighted differences between IL-13 and IL-4, it is important to stress that the overlap of the protein folds for the two proteins is quite similar.
Implication for IL-13 receptor binding
The recent X-ray crystal structure of IL-4 complexed to the IL-4 receptor a chain has provided insight into cytokine-receptor interactions. Furthermore, an abundance of prior mutational work provides additional information pertaining to the characteristics of the cytokine-receptor interactions. A strong overlap in functionality exists for IL-13 and IL-4 that is further exempli®ed by the fact that both receptors contain the same IL-4a chain. Therefore, the combination of the observed similarity in the protein folds, mutational data and the IL-4/ receptor complex provides a framework to investigate the interaction of IL-13 with its receptor.
A combination of mutational and kinetic analysis has identi®ed a distinct site on the IL-4 structure associated with IL-4Ra binding and a second site associated with signaling through the g c chain.
15 ± 17 The IL-4Ra binding site on IL-4 is associated with amino acid residues that comprise a surface formed by helices A (I5, E9, T13) and C (K77, R81, K84, R85 R88, N89, W91). The second site associated with signaling through the g c chain corresponds to residues in helices A (I11, N15) and D (R121, Y124, S125). Similar mutational work on IL-13 that alters its reactivity to IL-13R has identi®ed amino acids in helices A (E12, E15), C (R65, S68) and D (R108, F112), based on the predicted secondary structure for IL-13. 22, 23 The results of the mutational analysis were mapped onto a GRASP surface for both IL-4 and IL-13 ( Figure 6(a) and  (c) ). This analysis identi®es the potential IL-13 binding chain and IL-4Ra binding sites on IL-13, which are consistent with the IL-4 binding sites.
The X-ray structure of IL-4 complexed to IL-4Ra con®rmed the previous mutational data in identifying the a-chain binding site on IL-4, while further elucidating the speci®cs of the protein-receptor The sequence alignment of IL-13 with IL-4 based on the common secondary structure elements and disul®de bonds. Residues assigned to an a-helix are colored pink, to a b-strand are colored gray and the cysteine residues are colored red. The IL-4 mutational data and residues involved in the IL-4Ra binding site based on the IL-4/IL4Ra X-ray structure (PDB ID:1IAR) 18 are indicated on top of the sequence. The IL-13 mutational data are indicated on the bottom of the sequence. IL-4 residues involved in the IL4Ra and the g C binding sites identi®ed by mutational analysis are labeled with (*) and (), respectively. If the mutational data correlate with the binding interface de®ned by the IL-4/IL4Ra X-ray structure, the label is colored blue. IL-4 residues identi®ed as part of the IL-4Ra binding site from the X-ray structure without corresponding mutational data are labeled with (À). IL-13 residues involved in the IL-4Ra and the IL-13 binding chain binding sites identi®ed by mutational analysis are labeled with (#) and (&), respectively. The IL-4 sequence numbering is on top and the IL-13 sequence numbering is on the bottom.
Solution Structure of hIL -13 interaction. 18 The face of helices a A and a C from IL-4 are almost perpendicular to the L-shaped structure of IL-4Ra. Contact residues from IL-4 are predominantly polar and charged, while the complementary receptor epitope is composed of clusters of polar residues surrounded by hydrophobic residues. Three distinct clusters of residues are described where E9 and R88 from IL-4 are focal points in clusters I and II, respectively, where these residues are involved in hydrogen bonds and ionic bonds with numerous IL-4Ra residues. A number of additional IL-4 residues proximal to E9 and R88 complete the IL-4-receptor interface. The third cluster is described as primarily an electrostatic interaction that does not contribute signi®cantly to the binding af®nity, but facilitates complex formation. An overlay of the backbone atoms of IL-13 with IL-4 based primarily on a correlation of secondary structure elements provided a mechanism to establish a structure-based sequence alignment. This structure-based sequence alignment of IL-13 with IL-4 is shown in Figure 4 , where both the mutational data and the key contact residues from the IL-4/receptor X-ray structure are summarized. Again, there is a clear consistency between the IL-4 mutational and structure contact data, where the IL-13 mutational data correlate well with this information. The overlay of the IL-13 structure with IL-4 may then be used in a similar manner to create a model of IL-13 complexed with IL-4Ra.
By creating a best-®t superposition of IL-13 with IL-4 in the IL-4/IL-4Ra complex, a simple model of IL-13 complexed with IL-4Ra is obtained. An overlay of the IL-13 NMR structure with IL-4 from the IL-4/receptor X-ray structure based on the common secondary structure elements and Cys residues yielded a backbone r.m.s. of 1.55 A Ê . Additional re®nement of the IL-13/IL-4Ra complex was limited to minimization of the IL-13 side-chain conformations to remove obvious steric clashes between IL-13 and IL-4Ra. The IL-13/IL-4Ra model is illustrated in Figure 7 . It is readily apparent that the general interaction of IL-13 closely mimics the IL-4/IL-4Ra complex. Particularly, helices a A and a C pack approximately perpendicular against IL-4Ra (Figure 7(a) ). Furthermore, the framework of the IL-13 side-chain interactions with IL-4Ra mimics the network of interactions observed in the IL-4/IL-4Ra complex. In particular, E12 from IL-13 is positioned to mimic the bonding network of E9 from IL-4 with Y13, Y183 and S70 from IL-4Ra (Figure 7(b) ). Similarly, R65 from IL-13 is reasonably positioned to form a potential saltbridge with D72 from IL-4Ra (Figure 7(c) ). This interaction is comparable to the interaction of R88 from IL-4 with D72 from IL-4Ra. Distinctions between the IL-13/IL-4Ra model relative to the IL-4/IL-4Ra X-ray structure becomes apparent when comparison of the binding network that complement the E12 and R65 interaction with IL-4Ra is made. By reference to IL-4, residues proximal to E12 that are predicted to interact with IL-4Ra consist of IL-13 residues A9, E15, E16 and M66. These residues would correlate with T6, K12, T13 and N89 from IL-4 and interact with S70, Y183, Y127 and A71, respectively (Figure 7(b) ). Correspondingly, residues near R65 that are predicted to bind IL-4Ra comprise IL-13 residues I52, Q64 and M66 which correlate with IL-4 residues R53, N89 and W91. These IL-4 residues were shown to interact with F41 and V69 from IL-4Ra (Figure 7(c) ). While some comparable interactions are potentially present in the IL-13/IL-4a models, these interactions are clearly not optimal. Also, there exist some polarity or charge changes that would be predicted to have a detrimental affect on the af®nity of IL-13 with IL-4Ra. This is evident by comparison of the GRASP surfaces for IL-4 and IL-13 colored by electrostatic potential. A distinct surface is presented to IL-4Ra by the two proteins, where IL-4 presents a relatively higher negatively charged surface compared to IL-13 ( Figure 6(b) and (d) ). Conversely, the IL-13 surface is more hydrophobic compared to IL-4 with some positive charge characteristics. This analysis implies that while some key interactions consistent with the IL-4/IL-4Ra complex are present, the IL-13/IL-4Ra model predicts that some re-arrangement of the IL-13 interaction with IL-4Ra is required to optimize the secondary interactions and accommodate the residue substitutions between IL-13 and IL-4.
The apparent sub-optimal interface between IL-13 and IL-4Ra based on the IL-4/IL-4Ra complex appears consistent with both the experimental af®-nity of IL-13 with IL-4Ra and the assembly mechanism of IL-4 with IL-4R. A sequential order of binding of IL-4 to IL-4R has been proposed. 24, 25 First, IL-4 binds the IL-4Ra chain with high af®nity (K d 20-300 pM). The resulting complex then recruits the common g C chain to form the signaling heterodimer. Upon complex formation with IL-4Ra chain, IL-4 incurs a conformational change localized in the putative g C chain binding site. 15 ± 18 Presumably, the observed IL-4 conformational change is required to bind the g C chain binding. A similar mechanism appears consistent with the interaction of IL-13 with its receptor.
IL-13 does not bind IL-4R or the IL-4Ra chain in the absence of the IL-13 binding chain, 26 but binds to the IL-13 binding chain (IL-13Ra1) with relatively high af®nity (K d $ 4 nM). Following the sequential binding mechanism proposed for IL-4, IL-13 would appear to ®rst bind the IL-13 binding chain. The resulting complex then recruits the IL4Ra chain to from the signaling heterodimer. Upon complex formation with the IL-13 binding chain, Solution Structure of hIL-13 IL-13 would presumably incur a conformational change that would allow it to bind IL-4Ra. Again, this conformational change would probably resemble the change observed with IL-4 and result in a subtle re-arrangement in IL-13 helices a A and a C . Since the IL-13/IL-4Ra model reveals that the basic interaction network consistent with the IL-4/ IL-4Ra is present, presumably only a modest modi®cation in the helical packing would establish a comparable binding interface with IL-4/IL-4Ra complex and improve the af®nity of IL-13 with IL4Ra.
Materials and Methods
The uniform 15 N and 13 C-labeled 113 amino acid residue IL-13 was obtained as follows. The cDNA encoding the mature secreted portion of IL-13 was reconstructed with silent changes that optimized Escherichia coli codon usage and increased the AT content at the 5-prime end. The gene was subcloned into the phage T7-lac vector pRSET for expression in E. coli BL21(DE3). Growth and expression were at 37 C in shake¯asks with minimal medium supplemented with [
13 C]glucose and/or 15 Nlabeled ammonium sulfate. The protein was essentially completely insoluble. Cells were broken with a micro¯ui-dizer and insoluble IL-13 was collected and dissolved at about 2 mg/ml in 50 mM Ches (pH 9), 6 M guanidineHCl,1 mM EDTA, 20 mM DTT. The solution was diluted 20-fold into 50 mM Ches (pH 9), 3 M guanidine-HCl, 100 mM NaCl, 1 mM oxidized glutathione and dialyzed twice against ten volumes of 50 mM Ches (pH 9), 100 mM NaCl and once against ten volumes of 20 mM Mes (pH 6). Following clari®cation by centrifugation, IL-13 was adsorbed to SP-Sepharose and eluted with a gradient of NaCl in Mes buffer. Final puri®cation was by size-exclusion chromatography in 40 mM sodium phosphate, 40 mM NaCl on Superdex 75.
The NMR samples contained 1 mM IL-13 in a buffer containing 40 mM sodium phosphate (pH 6.0), 2 mM NaN 3 , 40 m M NaCl, in either 90 % H 2 O/10 % 2 H 2 O or 100 % 2 H 2 O. All NMR spectra were recorded at 25 C on a Bruker DRX 600 spectrometer equipped with a tripleresonance gradient probe. Spectra were processed using the NMRPipe software package 27 and analyzed with PIPP. 28 The assignments of the 1 H, 15 N, 13 CO, and 13 C resonances were based on the following experiments: CBCA (CO)NH, CBCANH, C(CO)NH, HC(CO)NH, HNHB, HNCO, HNHA, HNCA and HCCH-COSY (for reviews, see Bax et al. 29 and Clore & Gronenborn 30 ). The accuracy of the IL-13 NMR assignments was further con®rmed during the structure calculation and by sequential NOEs in the 15 N-edited NOESY-HMQC spectra and by NOEs between the b-strands observed in the 13 C-edited NOESY-HMQC and 15 N-edited NOESY-HMQC spectra. The present structure is based on the experimental distance and torsional angle restraints determined from the following series of spectra: HNHA, 31 C-long-range coupling constants 39 and the relative intensity of intra-molecular NOEs. 11 The f and c torsion angle restraints were obtained from 3 J NHa coupling constants measured from the HNHA experiment 31 and from chemical shift analysis using the TALOS program. 40 The minimum ranges employed for the f, c, and w torsion angle restraints were AE30
, AE50 , and AE20
, respectively. The NOEs assigned from the 3D 15 N and 13 C-edited NOESY experiments were classi®ed into strong, medium, weak and very weak, corresponding to interproton distance restraints where non-stereospeci®cally assignments were corrected appropriately for center averaging. 41 The structures were calculated using the hybrid distance geometry-dynamical simulated annealing method of Nilges et al. 42 with minor modi®cations 43 47 and a conformational database potential. 48, 49 The target function that is minimized during restrained minimization and simulated annealing comprises only quadratic harmonic terms for covalent geometry, b chemical shift restraints, square-well quadratic potentials for the experimental distance, radius of gyration and torsion angle restraints, and a quartic van der Waals term for non-bonded contacts. All peptide bonds were constrained to be planar and trans. There were no hydrogen-bonding, electrostatic, or 6-12 Lennard-Jones empirical potential energy terms in the target function. The radius of gyration can be predicted with reasonable accuracy on the basis of the number of residues using a relationship determined empirically from the analysis of high-resolution X-ray structures. 47 The force constant for the conformational database and radius of gyration potentials were kept relatively low throughout the simulation to allow the experimental distance and torsional angle restraints to be the predominant in¯uences on the resulting structures. The force constant for the NOE and dihedral restraints was 30 times and ten times stronger then the force constants used for the conformational database and radius of gyration potentials, respectively.
Overlay of the IL-13 solution structure with free IL-4 and IL-4 in the IL-4/IL4Ra complex was accomplished with Quanta (Molecular Simulations, Inc., San Diego, CA). Minimization of the IL-13 side-chains to remove steric clashes was accomplished with CHARMM (Molecular Simulations, Inc., San Diego, CA). Measurement of the interhelical angles and axial distances in the IL-13 and IL-4 structures was determined using INTERHLX (Dr Kyoko, University of Toronto).
Data deposition
Atomic coordinates for the 30 ®nal simulated annealing structures and the restrained minimized mean structure and the NMR chemical shift assignments of IL-13 have been deposited in the RCSB Protein Data Bank (PDB ID: 1ijz and 1iko) and the BioMagResBank (BMRB-5004), respectively.
